Slideshows Images Quizzes

Copyright © 2018 by RxList Inc. RxList does not provide medical advice, diagnosis or treatment. See additional information.

Kerydin

Last reviewed on RxList: 8/13/2018
Kerydin Side Effects Center

Last reviewed on RxList 8/13/2018

Kerydin (tavaborole) topical solution is an antifungal used to treat fungal infection (onychomycosis) of the toenails due to Trichophyton rubrum or Trichophyton mentagrophytes. Common side effects of Kerydin include:

  • ingrown toenail,
  • sloughing or peeling of dead skin,
  • skin redness, and
  • skin inflammation at the application site

Apply a dose of Kerydin to affected toenails once daily for 48 weeks. Kerydin may interact with other drugs. Tell your doctor all medications and supplements you use. During pregnancy, Kerydin should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

Our Kerydin (tavaborole) topical solution Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

SLIDESHOW

Rosacea, Acne, Shingles, Covid-19 Rashes: Common Adult Skin Diseases See Slideshow
Kerydin Professional Information

3 pharmacies near 20147 have coupons for Kerydin (Brand Names:Kerydin for 10ML of 5%)

CVS Pharmacy
CVS Pharmacy
$1788.85

Est. Regular Price

$1568.7

with free coupon

View Coupon
Walgreens
Walgreens
$1788.85

Est. Regular Price

$1597.96

with free coupon

View Coupon
Harris Teeter Pharmacy
Harris Teeter Pharmacy
$1788.85

Est. Regular Price

$1616.09

with free coupon

View Coupon

SIDE EFFECTS

Clinical Trials Experience

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

In two clinical trials, 791 subjects were treated with KERYDIN. The most commonly reported adverse reactions are listed below (Table 1).

Table 1: Adverse Reactions Occurring in ≥1% of KERYDIN Topical Solution, 5%-Treated Subjects and at a Greater Frequency than Observed with Vehicle

Preferred Term KERYDIN
N=791
n(%)
Vehicle
N=395
n(%)
Application site exfoliation 21 (2.7%) 1 (0.3%)
Ingrown toenail 20 (2.5%) 1 (0.3%)
Application site erythema 13 (1.6%) 0 (0%)
Application site dermatitis 10 (1.3%) 0 (0%)

Postmarketing Experience

The following adverse reactions have been identified during postmarketing use of KERYDIN. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug product exposure:

Hypersensitivity; contact allergy

Read the entire FDA prescribing information for Kerydin (Tavaborole Topical Solution, 5%)

QUESTION

Ringworm is caused by a fungus. See Answer
Related Resources for Kerydin

Related Drugs

© Kerydin Patient Information is supplied by Cerner Multum, Inc. and Kerydin Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors